Safeguard Scientifics, Inc. (NYSE:SFE) Files An 8-K Results of Operations and Financial Condition

0

Safeguard Scientifics, Inc. (NYSE:SFE) Files An 8-K Results of Operations and Financial Condition
ITEM 2.02. Results of Operations and Financial Condition.

On October26, 2017, Safeguard Scientifics, Inc. (the “Company”) issued a press release setting forth the Company’s financial information for the third quarter ended September30, 2017. A copy of the Company’s press release is attached hereto as Exhibit 99.1 and is hereby incorporated by reference.

This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

ITEM 9.01. Financial Statements and Exhibits.
99.1 Press Release of Safeguard Scientifics, Inc. dated October26, 2017.


SAFEGUARD SCIENTIFICS INC Exhibit
EX-99.1 2 tv477758_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1   Safeguard Scientifics Announces Third Quarter 2017 Financial Results Revised partner company aggregate revenue on track to grow between 23% and 26% in 2017 Conference call and webcast today at 9:00 a.m. ETRADNOR,…
To view the full exhibit click here

About Safeguard Scientifics, Inc. (NYSE:SFE)

Safeguard Scientifics, Inc. provides capital, as well as strategic, operational and management resources to growth-stage businesses. The Company participates in early- and growth-stage financings. The Company operates through two segments: Healthcare and Technology. The Healthcare segment’s companies focuses principally on medical technology (MedTech), including diagnostics and devices, and healthcare technology (HealthTech). The Technology segment’s companies focuses principally on digital media, financial technology (FinTech), and enterprise software, including mobile technology, cloud, Internet of Things (IoT) and big data. It holds interests in approximately 30 non-consolidated partner companies, which are included in the Healthcare and Technology segments. The Company provides management and operational support, as well as ongoing planning and development assessment. It provides mentoring, advice and guidance to develop partner company management.